Skip to content Accessibility statement

New research examines the risk of developing Long Covid

Posted on 25 April 2024

A new study carried out by researchers at the University of York suggests that on average 9% of people who catch COVID-19 may be at risk of developing Long Covid.

Long Covid is a chronic condition following a Covid infection which affects an estimated 1.9 million people in the UK.

However, the study, which reviewed 17 studies from around the world involving more than 40,000 Long COVID patients, found that the level of risk reported in the different studies varied greatly, with a range of 3% to 75%. 

The study reveals that one in four people with Long Covid may experience brain fog and one in three to four may develop anxiety or depression.

The findings, published in the journal General Hospital Psychiatry, suggest that full Covid vaccination makes sufferers four times less likely to have brain fog –  a term used to describe symptoms including poor concentration, feeling confused and cognitive impairment. 

Long-term sickness

With Long COVID a key factor in the record 2.8 million people off work in the UK due to long-term sickness, the researchers are calling for yearly COVID-19 vaccinations to be rolled out and should include all working-age people. 

The research was carried out in collaboration with the STIMULATE-ICP project, which is a £6.8 million NIHR-funded national research project led by University College London.

Lead author, Professor Christina van der Feltz—Cornelis, Chair of Psychiatry and Epidemiology at the Department of Health Sciences and at the University of York and Hull Medical School (HYMS), said: “I was struck by the figures that emerged from our study because they make it clear just how many people around the world are being affected by this debilitating condition.” 

“The discovery of a significant reduction in the risk of brain fog after Covid vaccination is particularly important in this context and provides support for continuation and extension of vaccination programmes, particularly to working-age people. 

“There is a societal tendency in the UK to think Covid is over, but Long Covid is having a profound and lasting effect on individuals and society as a whole, with many people leaving the workplace due to the condition. This is placing a heavy burden on the economy.” 

Chronic condition

Long Covid is a chronic condition following a Covid infection which affects an estimated 1.9 million people in the UK. Symptoms can include breathlessness, heart palpitations, joint pain and concentration problems.

The findings of the research also indicate that the mental health symptoms and brain fog experienced by people with Long Covid can actually get worse for many people over time. 24 months after acute infections, people were three to four times more likely to develop brain fog compared to during the peak of their Covid infection. The risk of developing depression or anxiety rose approximately 1.5 times in the same timeframe. 

Professor van der Feltz - Cornelis added: “This finding indicating that the condition often gets worse over time is concerning. It could be due to a decline in people’s mental health as living with Long Covid and the uncertainty that comes with the condition takes its toll. However, some early evidence suggests that living with Long Covid affects nerve cells in the brain so that might play a role as well.

“With so many people suffering from the severe effects of this condition, our study clearly points to the need for greater support, in addition to sustained vaccination programmes. We are very lucky to be one of the only countries to have dedicated Long Covid centres, but we need more joined-up treatment of the mental and physical symptoms of the condition and greater resources for effective treatments, rehabilitation and occupational therapy so that people are able to recover and avoid losing their careers and livelihoods. ”

Further information:

This article was amended on 5 June 2024. The study suggests the risk of developing Long Covid from Covid infection is 9% on average, not 28% as an earlier version said, due to an error. The study identified a large range in the level of risk reported in the studies analysed of between 3% and 74%. It is very important to us to promptly correct any factual errors and we apologise for this mistake.

Explore more news

Media enquiries

Shelley Hughes
Deputy Head of Media Relations (job share)

Tel: +44 (0)1904 323918

Related research themes